Education
About Us
Working with TipRanks
Follow Us
MDxHealth (MDXH)
NASDAQ:MDXH
MDXH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.49 - $3.50
Previous CloseN/A
Volume27.23K
Average Volume (3M)89.55K
Market Cap
$73.75M
Enterprise Value$64.25M
Total Cash (Recent Filing)$26.20M
Total Debt (Recent Filing)$526.00K
Price to Earnings (P/E)―
Beta-1761.57
Next Earnings
May 14, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.27
Shares Outstanding49,497,334
10 Day Avg. Volume152,612
30 Day Avg. Volume89,548
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.46
Enterprise Value/Ebitda-3.30
Forecast
1Y Price Target
$6.50Price Target Upside357.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
MDxHealth News
PremiumCompany Announcements
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call
PremiumCompany Announcements
Mdxhealth Reports Strong 2024 Financial Performance with 28% Revenue Growth
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMDxHealth reported revenues above estimates, showing strong testing volume growth across both tissue- and liquid-based assays.
Growth ProspectsThe Company increased 2024 revenue guidance, reflecting confidence in future revenue growth.
Bears Say
Market SentimentShares are down 48% year-to-date, driven down by financing overhang, limited market liquidity, and a somewhat negative sentiment toward the broader diagnostics space.
---
Ownership Overview
―
Insiders
0.08%
Mutual Funds
34.51% Other Institutional Investors
65.41% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MDXH FAQ
What was MDxHealth’s price range in the past 12 months?
MDxHealth lowest stock price was $1.49 and its highest was $3.50 in the past 12 months.
What is MDxHealth’s market cap?
MDxHealth’s market cap is $73.75M.
When is MDxHealth’s upcoming earnings report date?
MDxHealth’s upcoming earnings report date is May 14, 2025 which is in 64 days.
How were MDxHealth’s earnings last quarter?
MDxHealth released its earnings results on Feb 26, 2025. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.192 by $0.052.
Is MDxHealth overvalued?
According to Wall Street analysts MDxHealth’s price is currently Undervalued.
Does MDxHealth pay dividends?
MDxHealth does not currently pay dividends.
What is MDxHealth’s EPS estimate?
MDxHealth’s EPS estimate is -0.13.
How many shares outstanding does MDxHealth have?
MDxHealth has 49,497,334 shares outstanding.
What happened to MDxHealth’s price movement after its last earnings report?
MDxHealth reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.192. Following the earnings report the stock price went up 1.639%.
Which hedge fund is a major shareholder of MDxHealth?
Currently, no hedge funds are holding shares in MDXH
---
MDxHealth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.50 (357.75% Upside)
$6.50 (357.75% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.62%
12-Months-Change
Fundamentals
Return on Equity
-345.31%
Trailing 12-Months
Asset Growth
21.84%
Trailing 12-Months
Company Description
MDxHealth
MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. It offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
---
MDXH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong revenue growth and improved financial performance, despite a decline in gross margins and increased operating expenses. The company expressed confidence in achieving its revenue and adjusted EBITDA goals for 2025, driven by increased test volumes and strategic execution.Read More>---
MDXH Stock 12 Month Forecast
Average Price Target
$6.50
▲(357.75% Upside)
Technical Analysis
Best Analysts Covering MDXH
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-25.15%
reiterated a buy rating 13 days ago
Copying Thomas Flaten's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -25.15% per trade.
---